Skip to content

clinical study of Robot-Assisted Radical Cystectomy for invasive bladder cancer

clinical study of Robot-Assisted Radical Cystectomy for invasive bladder cancer - RARC for bladder cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028469
Enrollment
3
Registered
2017-08-01
Start date
2017-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

invasive bladder cancer

Interventions

Radical cystectomy performed with daVinci Si system,

Sponsors

Jichi Medical University, Satiama Medical Center Department of Urology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Invasive bladder cancer cT1-2N0M0 ,who obtained written informed consent

Exclusion criteria

Exclusion criteria: 1 The patient seems to be difficult for robot-assisted surgery due to previous surgery. 2. The patient with multiple cancers (cancer combined cancer and disease-free period within five years of different multiple cancer). 3. patients with impossible discontinuation of anticoagulants. 4. patients requiring blood transfusion due to anemia or bleeding. 5. morbid obesity (bimi35 or higher) 6. renal transplant history. 7. dialysis patients. 8. pregnant women or pregnant or lactating women 9. patients with a mental illness or psychiatric symptoms. 10. patients who is difficult for surgical treatment because of serious complications (angina pectoris, myocardial infarction, serious arrhythmias, uncontrolled diabetes, malignant hypertension, etc. 11. patients who have renal dysfunction (serum creatinine levels 1.5mg/dl or more), liver dysfunction (AST, ALT 100IU/l or more). 12. patients with bacterial infections requiring treatments. 13. patients with interstitial pneumonitis and pulmonary fibrosis. 14. patients with severe drug hypersensitivity, drug allergies. 15. minors 16. patients seemed unfit for other reasons.

Design outcomes

Primary

MeasureTime frame
Intra and and postoperative complications and their contents

Secondary

MeasureTime frame
operation time, duration for anesthesia, a, bleeding, postoperative use for pain medication, postoperative hospitalization period, histopathological findings

Countries

Japan

Contacts

Public ContactTomoaki Miyagawa

Jichi Medical University, Satiama Medical Center Department of Urology

sh2-miya@jichi.ac.jp048-647-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026